InnoCare Pharma Limited (SHA:688428)
China flag China · Delayed Price · Currency is CNY
29.89
+3.24 (12.16%)
At close: Sep 12, 2025

InnoCare Pharma Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Net Income
-208.88-440.63-631.26-886.59-64.55-391.4
Upgrade
Depreciation & Amortization
103.5695.5988.1567.4833.0811.19
Upgrade
Other Amortization
11.0511.5411.230.930.630.27
Upgrade
Loss (Gain) From Sale of Assets
-0---0-
Upgrade
Asset Writedown & Restructuring Costs
0.10.120.02---
Upgrade
Loss (Gain) From Sale of Investments
-32.54-6.26-5.57-6.46-6.7-
Upgrade
Loss (Gain) on Equity Investments
---9.710.6-
Upgrade
Stock-Based Compensation
21.59-10.7965.1129.48126.44215.62
Upgrade
Provision & Write-off of Bad Debts
0.681.50.27---
Upgrade
Other Operating Activities
-17.751.8849.17195.01-40.7548.35
Upgrade
Change in Accounts Receivable
-87.96-63.34-194.53-82.65-45.15-0.12
Upgrade
Change in Inventory
20.7147.65-42.46-52.12-8.04-1.88
Upgrade
Change in Accounts Payable
44.59-2.8-5.613479.08-2.68
Upgrade
Change in Unearned Revenue
----8.7517.19-51.39
Upgrade
Change in Other Net Operating Assets
---34.4275.22-0.49
Upgrade
Operating Cash Flow
-144.84-365.55-665.49-565.55167.06-172.52
Upgrade
Capital Expenditures
-48.02-78.23-254.65-227.24-169.77-251
Upgrade
Sale of Property, Plant & Equipment
0.0100.01-0.02-
Upgrade
Cash Acquisitions
--1.15---
Upgrade
Sale (Purchase) of Intangibles
----143.09-1.44-0.27
Upgrade
Investment in Securities
1,2391,056795.85-1,529-1,638-889.03
Upgrade
Other Investing Activities
100.64133.75118.71173.3479.5733.34
Upgrade
Investing Cash Flow
1,2911,111661.06-1,726-1,730-1,107
Upgrade
Long-Term Debt Issued
-1,18533.832550-
Upgrade
Total Debt Issued
1,2581,18533.832550-
Upgrade
Short-Term Debt Repaid
------9.02
Upgrade
Long-Term Debt Repaid
--990.41-28.98-21.78-14.92-4.99
Upgrade
Total Debt Repaid
-1,085-990.41-28.98-21.78-14.92-14.02
Upgrade
Net Debt Issued (Repaid)
173.01194.914.82303.2335.08-14.02
Upgrade
Issuance of Common Stock
26.5718.59.952,9232,5272,356
Upgrade
Repurchase of Common Stock
-13.35-13.35-6.3---
Upgrade
Common Dividends Paid
-378.96-362.93-1.15---
Upgrade
Other Financing Activities
-31.96-122.73-6.01-131.95-17.74-103.87
Upgrade
Financing Cash Flow
-224.7-285.591.313,0952,5452,238
Upgrade
Foreign Exchange Rate Adjustments
6.1116.9225.7139.9-45.3-251.78
Upgrade
Net Cash Flow
927.79476.922.58942.5936.6706.73
Upgrade
Free Cash Flow
-192.86-443.78-920.14-792.79-2.71-423.51
Upgrade
Free Cash Flow Margin
-14.60%-43.96%-124.59%-126.76%-0.26%-31049.41%
Upgrade
Free Cash Flow Per Share
-0.12-0.26-0.54-0.54-0.00-0.44
Upgrade
Cash Interest Paid
---3.262.531.14
Upgrade
Cash Income Tax Paid
89.2589.2558.78---
Upgrade
Levered Free Cash Flow
-133.1-664.21-777.19-236.9535.82-412.99
Upgrade
Unlevered Free Cash Flow
-101.51-643.09-755.19-226.2937.47-412.28
Upgrade
Change in Working Capital
-22.65-18.49-242.6-75.1118.3-56.55
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.